TNO155 (#HY-136173) and SHP099 (#HY-100388A) were purchased from MedChemExpress, and ceritinib (#S7083), lorlatinib (#S7536), and crizotinib (#S1068) were purchased from Selleck Chemicals. Inhibitors were resuspended in DMSO. For murine experiments, lorlatinib (#HY-12215) and TNO155 (#HY-136173) were purchased from MedChemExpress or TNO155 was provided by Novartis AG. Drugs were resuspended in final concentrations of 0.5% methylcellulose + 0.5% Tween 80 in water.
Tno155
Manufactured by MedChemExpress
TNO155 is a laboratory equipment product offered by MedChemExpress. It is designed for use in scientific research and experimentation. The core function of TNO155 is to provide a controlled environment for various experimental procedures.
Automatically generated - may contain errors
Lab products found in correlation
Lorlatinib, by Selleck Chemicals (1 mentions)
Crizotinib, by Selleck Chemicals (1 mentions)
Ceritinib, by Selleck Chemicals (1 mentions)
Lorlatinib, by MedChemExpress (1 mentions)
Shp099, by MedChemExpress (1 mentions)
Capmatinib, by Selleck Chemicals (1 mentions)
Adagrasib, by MedChemExpress (1 mentions)
Nci h23, by American Type Culture Collection (1 mentions)
Bi 3406, by MedChemExpress (1 mentions)
Sotorasib, by MedChemExpress (1 mentions)
Nci h2122, by American Type Culture Collection (1 mentions)
Rpmi 1640 medium, by Merck Group (1 mentions)
2 protocols using tno155
1
Murine Tumor Model Drug Preparation
2
NSCLC Cell Line Authentication and Compound Screening
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
The NSCLC NCI-H23 and NCI-H2122 cell line were purchased from the ATCC. The authenticity of the cells was confirmed by short tandem repeat profiling on September 9, 2020. All cell lines were authenticated and verified as mycoplasma free every month. The cells were maintained in a humidified atmosphere of 5% CO 2 at 37 C in RPMI1640 medium (Sigma-Aldrich Corp.) supplemented with 10% FBS and 1% penicillin-streptomycin. Sotorasib, adagrasib, BI-3406, and TNO155 were obtained from MedChemExpress (Monmouth Junction); crizotinib was purchased from Chem Scene (Monmouth Junction); capmatinib was purchased from Selleck Chemicals; and selumetinib was bought from ShangHai Biochempartner. Compounds were dissolved in dimethyl sulfoxide to a final concentration of 10 mmol/L and stored at À20 C until use.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!